Role of eIF3 p170 in controlling synthesis of ribonucleotide reductase M2 and cell growth
- 19 April 2004
- journal article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 23 (21), 3790-3801
- https://doi.org/10.1038/sj.onc.1207465
Abstract
Translation initiation in eukaryotes is a rate-limiting step in protein synthesis. It is a complicated process that involves many eukaryotic initiation factors (eIFs). Altering the expression level or the function of eIFs may influence the synthesis of some proteins and consequently cause abnormal cell growth and malignant transformation. P170, the largest putative subunit of eIF3, has been found elevated in human breast, cervical, esophageal, and lung cancers, suggesting that p170 may have a potential role in malignant transformation and/or cell growth control. Our recent studies suggested that p170 is likely a translational regulator and it may mediate the effect of mimosine on the translation of a subset mRNAs. Mimosine, a plant nonprotein amino acid, inhibits mammalian DNA synthesis, an essential event of cell growth. The rate-limiting step in DNA synthesis is the conversion of the ribonucleotides to their corresponding deoxyribonucleotides catalysed by ribonucleotide reductase of which the activity is regulated by the level of its M2 subunit. It has been reported that inhibiting the activity of M2 also inhibits cell growth. To understand the relationship between protein and DNA synthesis and between p170 and cell growth control, we investigated in this study whether p170 regulates the synthesis of M2 and, thus, cell growth. We found that altering the expression level of p170 changes the synthesis rate of both M2 and DNA. Decreasing p170 expression in human lung cancer cell line H1299 and breast cancer cell line MCF7 significantly reversed their malignant growth phenotype. However, the overall [35S]methionine incorporation following dramatic decrease in p170 expression was only 25% less than the control cells. These observations, together with our previous findings, suggest that p170 may regulate the translation of a subset mRNAs and its elevated expression level may be important for cancer cell growth and for maintaining their malignant phenotype.Keywords
This publication has 40 references indexed in Scilit:
- Regulation of Internal Ribosome Entry Site-mediated Translation by Eukaryotic Initiation Factor-2α Phosphorylation and Translation of a Small Upstream Open Reading FrameJournal of Biological Chemistry, 2002
- Inhibition of Human Cancer Cell Growth by Inducible Expression of Human Ribonucleotide Reductase Antisense cDNAAntisense and Nucleic Acid Drug Development, 2000
- Characterization of the Promoter of the Human Ribonucleotide Reductase R2 GeneBiochemical and Biophysical Research Communications, 2000
- Reversal of Hydroquinone-Mediated Suppression of T Cell Proliferation by Transfection of the M2 Subunit of Ribonucleotide ReductaseToxicology and Applied Pharmacology, 1998
- The Dual Effect of Mimosine on DNA ReplicationExperimental Cell Research, 1997
- Detection of a sub‐set of polysomal mRNAs associated with modulation of hypusine formation at the G1‐S boundary Proposal of a role for eIF‐5A in onset of DNA replicationFEBS Letters, 1995
- Mimosine Arrests DNA Synthesis at Replication Forks by Inhibiting Deoxyribonucleotide MetabolismPublished by Elsevier BV ,1995
- Malignant transformation by H‐ras results in aberrant regulation of ribonucleotide reductase gene expression by transforming growth factor‐β1Journal of Cellular Biochemistry, 1995
- Regulation and drug resistance mechanisms of mammalian ribonucleotide reductase, and the significance to DNA synthesisBiochemistry and Cell Biology, 1990
- Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' capNature, 1990